News

Engineered dendritic cells (right) acquire tumor-derived extracellular vesicles that contain cancer antigens (left), stimulating anti-tumor immunity. Credit: EPFL/Ella Maru Studio CC-BY-SA 4.0

Engineering dendritic cells boosts cancer immunotherapy

— EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a full-blown immunotherapy strategy.

© EPFL/iStock (quantic69)

How cells survive oxidative stress

— EPFL scientists have identified a molecular pathway that protects cells from lipid oxidation and ferroptosis, a regulated form of cell death involved in aging and several diseases.

Five decades of research on fly immunity have been studied. ©iStock

Scientists investigate 400 biological cold cases

— A team of EPFL scientists tested the reproducibility of five decades of research on fly immunity. Most of those research results proved to be valid, but the team made one surprising discovery: the non-reproducible results were most often found in highly prestigious journals.

Anne-Florence Bitbol © 2025 EPFL

Anne-Florence Bitbol promoted to Associate Professor

— The Board of the Swiss Federal Institutes of Technology has announced the appointment of professors at EPFL. Anne-Florence Bitbol, currently Tenure Track Assistant Professor at EPFL, has been promoted to Associate Professor of Life Sciences in the School of Life Sciences.

Mackenzie Mathis at the SGV meeting in Zurich, on December 3, 2025. © Melisa Muhtari

"Respect for animals is a core value for me"

— The Swiss Laboratory Animal Science Association awarded on Wednesday its 2025 Prize to neuroscientist Mackenzie Mathis, Professor at EPFL, “for her outstanding contribution to the refinement of animal research.”